Ravid Straussman

Azimuth Technologies Ltd. is a world leader in target acquisition, fire coordination, navigation, and orientation solutions for defense applications. Azimuth solutions are based on the first-hand battlefield experience of their staff and are the systems of choice for the IDF. It focuses on the development of equipment which is effective and affordable. Its systems are designed to enable modern armies-artillery, armor, mortar, intelligence, special forces, mounted infantry, supporting airborne platforms to maximize the effectiveness of their fire. Azimuth systems create a common language for the various units participating in the modern, integrated battlefield and directly target the needs of mobile and rapid deployment forces. Its navigation and orientation technologies deliver the information commanders need for flexible maneuver and full situational awareness. The company was founded by Mr. Shlomi Reisman in 1987 and is headquartered in Raanana, Israel.

Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA.

aMoon Ventures Y Sh Ltd (aMoon Ventures) is an venture capital firm founded in 2016 by Marius Nacht and Dr. Yair Schindel. The firm is headquartered in Israel.

Maoz Association provides social services. The Israeli company was founded by Yair Schindel.

DayTwo Ltd. engages in the provision of glycemic control solution. It focuses on personalized nutrition and actionable insights that allow patient to live healthier, and maintain target blood glucose levels. It offers solutions for employers, clinicians, and patients. The company was founded by Marius Nacht, Yuval Ofek, Lihi Segal, and Yair Schindel in 2015 and is headquartered in Adanim, Israel.

Start-Up Nation Central Ltd. engages and connects companies and countries to the people and technologies. It activities are reflected in the establishment of new innovation centers in Israel. The company is a non-profit dedicated to strengthening Israel?s innovation ecosystem and connecting world business, government, and NGO leaders to the people and technologies in Israel that can help them solve their most pressing problems. It provides personal and professional guide through the maze of cutting-edge Israeli innovation. Start-Up Nation Central was founded in 2012 and is headquartered in Tel Aviv, Israel.

Aummune Ltd. develops pre-clinical cancer therapeutics. The company was founded by Guy Neev and Marius Nacht and is headquartered in Rehovot, Israel.

Nobio Ltd. develops nano-polymer additive that protects against microbial infection which transforms regular implantable and non-implantable devices. The company was founded by Yair Schindel and Ervin Weiss in 2015 and is headquartered in Petach Tiqva, Israel.

OmniGuide Holdings, Inc. engages in the innovation of medical technology. It provides energy surgical tools to clinicians and patients. It operates through the OmniGuide Surgical and Domain Surgical business units, which create surgical technologies that deliver energy, resulting in the preservation of healthy tissues. The company was founded on March 6, 2015 and is headquartered in DE.

Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021.

Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation.

Pharma Two B Ltd. operates as a biopharmaceutical company which focuses on developing treatments for Parkinson’s disease. The firm focuses on Fixed-Dose-combinations of two or more drugs with synergistic effects, providing clinical value and regulatory pathways. The company was founded by Ehud Marom and Nurit Livnah in December 2007 and is headquartered in Rehovot, Israel.